Lindbrook Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $2.56M | Buy |
12,237
+848
| +7% | +$178K | 0.24% | 65 |
|
2024
Q4 | $2.02M | Sell |
11,389
-110
| -1% | -$19.5K | 0.18% | 75 |
|
2024
Q3 | $2.27M | Buy |
11,499
+265
| +2% | +$52.3K | 0.2% | 71 |
|
2024
Q2 | $1.93M | Buy |
11,234
+751
| +7% | +$129K | 0.18% | 81 |
|
2024
Q1 | $1.91M | Buy |
10,483
+689
| +7% | +$125K | 0.18% | 80 |
|
2023
Q4 | $1.52M | Buy |
9,794
+591
| +6% | +$91.6K | 0.15% | 88 |
|
2023
Q3 | $1.37M | Buy |
9,203
+629
| +7% | +$93.8K | 0.15% | 90 |
|
2023
Q2 | $1.16M | Sell |
8,574
-1,781
| -17% | -$240K | 0.12% | 105 |
|
2023
Q1 | $1.65M | Sell |
10,355
-253
| -2% | -$40.3K | 0.19% | 77 |
|
2022
Q4 | $1.71M | Buy |
10,608
+944
| +10% | +$153K | 0.21% | 77 |
|
2022
Q3 | $1.3M | Buy |
9,664
+1,239
| +15% | +$166K | 0.22% | 60 |
|
2022
Q2 | $1.29M | Buy |
8,425
+163
| +2% | +$25K | 0.21% | 61 |
|
2022
Q1 | $1.34M | Sell |
8,262
-295
| -3% | -$47.8K | 0.21% | 68 |
|
2021
Q4 | $1.16M | Buy |
8,557
+4,077
| +91% | +$552K | 0.18% | 71 |
|
2021
Q3 | $483K | Hold |
4,480
| – | – | 0.13% | 72 |
|
2021
Q2 | $505K | Sell |
4,480
-904
| -17% | -$102K | 0.11% | 76 |
|
2021
Q1 | $583K | Buy |
5,384
+114
| +2% | +$12.3K | 0.13% | 60 |
|
2020
Q4 | $565K | Buy |
5,270
+653
| +14% | +$70K | 0.14% | 57 |
|
2020
Q3 | $404K | Sell |
4,617
-39
| -0.8% | -$3.41K | 0.11% | 75 |
|
2020
Q2 | $457K | Buy |
4,656
+429
| +10% | +$42.1K | 0.14% | 56 |
|
2020
Q1 | $322K | Sell |
4,227
-673
| -14% | -$51.3K | 0.12% | 71 |
|
2019
Q4 | $434K | Buy |
4,900
+153
| +3% | +$13.6K | 0.15% | 69 |
|
2019
Q3 | $359K | Buy |
4,747
+214
| +5% | +$16.2K | 0.14% | 74 |
|
2019
Q2 | $329K | Sell |
4,533
-312
| -6% | -$22.6K | 0.13% | 81 |
|
2019
Q1 | $390K | Buy |
4,845
+965
| +25% | +$77.7K | 0.16% | 66 |
|
2018
Q4 | $357K | Buy |
+3,880
| New | +$357K | 0.18% | 61 |
|